TEVOGEN BIO HOLDINGS INC (TVGN) Stock Price, Quote, News and Overview
NASDAQ:TVGN - Nasdaq - US88165K1016 - Common Stock - Currency: USD
TVGN Quote, Performance and Key Statistics
TEVOGEN BIO HOLDINGS INC
NASDAQ:TVGN (2/4/2025, 8:12:46 PM)
Premarket: 1.47 0 (0%)1.47
+0.01 (+0.68%)
The current stock price of TVGN is 1.47 USD. In the past month the price increased by 31.25%.
TVGN Latest News, Press Releases and Analysis
Which stocks are experiencing notable movement on Monday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
These stocks that are showing activity before the opening bell on Monday.
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections.Tevogen Bio may also utilize the...
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
WARREN, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, Chairman and founding CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”)...
TVGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 14.58 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.27 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About TVGN
Company Profile
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. The company is headquartered in Warren, New Jersey and currently employs 17 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The firm is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.
Company Info
TEVOGEN BIO HOLDINGS INC
15 Independence Boulevard, Suite 410
WARREN NEW JERSEY US
Employees: 17
Company Website: https://tevogen.com/
Phone: 16468078832
TVGN FAQ
What is the stock price of TVGN?
The current stock price of TVGN is 1.47 USD.
What is the symbol for TEVOGEN BIO HOLDINGS INC stock?
The exchange symbol of TEVOGEN BIO HOLDINGS INC is TVGN and it is listed on the Nasdaq exchange.
On which exchange is TVGN stock listed?
TVGN stock is listed on the Nasdaq exchange.
Is TVGN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TVGN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TVGN.
Does TVGN stock pay dividends?
TVGN does not pay a dividend.
What is the Price/Earnings (PE) ratio of TVGN?
The PE ratio for TVGN is 3.87. This is based on the reported non-GAAP earnings per share of 0.38 and the current share price of 1.47 USD.
What is the Short Interest ratio of TVGN stock?
The outstanding short interest for TVGN is 8.54% of its float.
TVGN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to TVGN.
TVGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TVGN. TVGN has a bad profitability rating. Also its financial health evaluation is rather negative.
TVGN Financial Highlights
Over the last trailing twelve months TVGN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 375% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 337.72% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TVGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TVGN. The Buy consensus is the average rating of analysts ratings from 7 analysts.